SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is currently trending due to the FDA's recent approval of its oral Wegovy pill, marking a significant milestone as the first GLP-1-based oral therapy for weight management. The community is buzzing about this "game changer," highlighting its convenience over injections and Novo Nordisk's first-mover advantage against competitors like Eli Lilly, with many anticipating a substantial rebound for the stock.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is experiencing a significant surge, primarily driven by recent high-grade silver drill results from its Vortex system. This has ignited a strong rally, further fueled by rising precious metal prices and widespread speculation about a short squeeze. The community is actively discussing major investor Eric Sprott's continued substantial investments and the long-term potential of the company's vast silver and gold deposits.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. (SOC) is currently trending as federal regulators have approved the restart plan for its Las Flores Pipeline system, shifting regulatory authority from California to federal oversight. This development has ignited significant community discussion regarding a potential short squeeze and a major upside move, with many seeing it as a critical de-risking event for the company's California offshore oil assets, despite some lingering concerns about its financial standing.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is experiencing a significant rally, fueled by tightening global supply, particularly from imminent Chinese export restrictions, and soaring industrial demand from sectors like EV batteries and solar. The community is buzzing about a potential silver squeeze, highlighting its historical undervaluation and anticipating substantial price discovery, while some voices warn of an extended, overbought market.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is experiencing intense trading activity and significant volatility, driven by a series of recent partnerships and product developments in its niche flexible thin-film solar technology for space and defense. The community is actively debating its low float and short-squeeze potential, eyeing ambitious price targets, even as historical concerns over dilution lead to polarized sentiment amidst its specialized role in the evolving space energy sector.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X is trending due to recent bullish commentary from Citron Research and Infleqtion's strategic partnerships, including collaborations for high-precision quantum timing in GPS-denied environments and defense applications. The community is actively discussing Infleqtion's real-world applications and strong revenue pipeline, positioning it as a significantly undervalued leader compared to other quantum pure-plays. Anticipation is building for the upcoming merger, which is expected to unlock substantial institutional investment and elevate Infleqtion's profile in the critical quantum technology sector.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is experiencing heightened activity as the biotech community eagerly awaits an imminent FDA decision on Narsoplimab for TA-TMA, a first-in-class treatment for a life-threatening condition with no currently approved therapies. The recent closing of its asset purchase and license agreement with Novo Nordisk, which substantially strengthened its balance sheet and triggered a share repurchase program, has intensified community discussions around potential short squeeze scenarios and the drug's market potential.

VisionWave Holdings, Inc. engages in the forefront of revolutionizing defense capabilities by integrating advanced artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. The company was founded on September 3, 2024 and is headquartered in Wilmington, DE.

VisionWave Holdings Inc.

VisionWave Holdings, Inc.

VisionWave Holdings (VWAV) is trending following a recently issued U.S. patent for its real-time RF movement and position imaging technology, further solidifying its AI and defense capabilities. The community is actively discussing this patent win, alongside the company's recent acquisition of Solar Drone, believing these catalysts could drive significant volume and spark a short squeeze for the low-float AI/Defense stock, drawing comparisons to successful industry peers.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience (RGC) is capturing significant attention, primarily driven by historical memories of its prior explosive price movements, igniting speculation for another substantial run. Community discussions are centered on its exceptionally low float, high insider ownership, and increasing cost to borrow, leading many to anticipate a potential short squeeze. Traders are actively debating whether these structural characteristics will lead to a new parabolic surge, echoing past volatility seen in similar high-risk plays.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending following a muted 2026 financial outlook, which projects declines in COVID product sales and impacts from patent expirations. This challenging guidance, coupled with news of a patient death in a hemophilia drug trial, is sparking significant investor frustration and renewed calls for leadership changes. While some community members highlight the attractive dividend and long-term value, many are expressing discontent with the stock's persistent underperformance and its strategy in the competitive obesity market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zevenbergen Capital Investments LLC Grows Position in Mirion Technologies, Inc. $MIR

Zevenbergen Capital Investments LLC boosted its stake in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 2,169.6% in the 3rd quarter, according to its most recent disclosure with the...

Lawrence Kingsley Sells 350,000 Shares of Mirion Technologies (NYSE:MIR) Stock

Mirion Technologies, Inc. (NYSE:MIR - Get Free Report) Director Lawrence Kingsley sold 350,000 shares of the stock in a transaction dated Wednesday, December 10th. The shares were sold at an average...

Insider Selling: Mirion Technologies (NYSE:MIR) Director Sells 350,000 Shares of Stock

Mirion Technologies, Inc. (NYSE:MIR - Get Free Report) Director Lawrence Kingsley sold 350,000 shares of the company's stock in a transaction on Wednesday, December 10th. The stock was sold at an...

Maverick Capital Ltd. Has $114.28 Million Position in Mirion Technologies, Inc. $MIR

Maverick Capital Ltd. decreased its stake in Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 36.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities...

Walleye Capital LLC Sells 204,323 Shares of Mirion Technologies, Inc. $MIR

Walleye Capital LLC lessened its stake in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 71.4% in the second quarter, according to the company in its most recent 13F filing with the...

Citigroup Lowers Mirion Technologies (NYSE:MIR) Price Target to $33.00

Citigroup cut their price target on shares of Mirion Technologies from $35.00 to $33.00 and set a "buy" rating on the stock in a research report on Monday...

Hood River Capital Management LLC Acquires New Holdings in Mirion Technologies, Inc. $MIR

Hood River Capital Management LLC bought a new position in Mirion Technologies, Inc. (NYSE:MIR - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and...

Mirion Technologies, Inc. $MIR Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its holdings in Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 187.2% in the second quarter, according to its most recent disclosure with the SEC. The fund owned...

Northland Capmk Has Strong Forecast for MIR FY2025 Earnings

Mirion Technologies, Inc. (NYSE:MIR - Free Report) - Investment analysts at Northland Capmk boosted their FY2025 earnings estimates for Mirion Technologies in a report issued on Thursday, December...

Arrowstreet Capital Limited Partnership Cuts Position in Mirion Technologies, Inc. $MIR

Arrowstreet Capital Limited Partnership trimmed its holdings in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 18.2% in the second quarter, according to its most recent disclosure...

Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. It operates through the Nuclear and Safety, and Technologies segments. The Nuclear and Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense. The Technologies segment involves nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.

Current Price	$23.89
Prev Close	$23.81
Open	$23.71
Dividend Yield	0.00%
50-Day Moving Average	$25.36
Beta	1.39
Avg. Volume	3.8M
PE Ratio	202.12

52-Week High	$30.28
52-Week Low	$12.00
Market Capitalization	$6.13B
EPS (Annual)	-$0.1761
Price to Book	3.24
Revenue Per Employee	$300,979.02
Enterprise Value/EBITDA	N/A

MIR
Mirion Technologies Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MIR News

MIRMirion Technologies Inc. - Ordinary Shares - Class A